Newland Pharma Co., Ltd. Announcement on the Proposed Profit Distribution Plan for 2025
The company and all members of its board of directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or significant omissions.
Special Notice:
- The profit distribution plan for 2025 proposed by Newland Pharma Co., Ltd. (hereinafter referred to as the "Company") is: based on the Company's total share capital of 392,078,400 shares as of December 31, 2025, a cash dividend of RMB 2 (tax inclusive) per 10 shares will be distributed to all shareholders. In 2025, the Company will not implement capital reserve to increase share capital or issue bonus shares.
- The Company's cash dividend proposal does not involve circumstances that may be subject to other risk warnings as stipulated in Article 9.4 of the "Shenzhen Stock Exchange GEM Stock Listing Rules".
- After the Company's 2025 profit distribution plan is deliberated and approved by the shareholders' meeting, the Company will issue a separate announcement on the implementation of equity distribution in accordance with the requirements of relevant laws, regulations, and normative documents, clarifying information such as the equity registration date and ex-rights/ex-dividend date. Investors are requested to pay attention to the relevant announcements.
I. Deliberation Procedures The Sixth Audit Committee of the Sixth Board of Directors held its second meeting in 2026 on March 17, 2026, and the Second Special Meeting of Independent Directors of the Sixth Board of Directors was held on March 17, 2026. The Eleventh Meeting of the Sixth Board of Directors was held on March 18, 2026. The "Proposal on the Company's 2025 Profit Distribution Plan" was deliberated and approved separately. The Company's 2025 profit distribution plan needs to be deliberated and approved by the Company's 2025 Annual Shareholders' Meeting before it can be implemented.
(I) Audit Committee Deliberation Status The second meeting of the Audit Committee of the Sixth Board of Directors in 2026 deliberated and approved the "Proposal on the Company's 2025 Profit Distribution Plan". The Audit Committee believes that the Company's 2025 profit distribution plan complies with the relevant provisions of the "Company Law of the People's Republic of China" (hereinafter referred to as the "Company Law"), the "Articles of Association", and other laws and regulations, is in the interest of shareholders, and is conducive to fully protecting the legitimate rights and interests of small and medium investors, and is in line with the Company's operating performance and future development.